Schistosome vaccine testing: lessons from the baboon model.

Area of Science:

• Immunology
• Vaccinology
• Parasitology

Background:

• Radiation-attenuated schistosome vaccines elicit high protection in animal models.
• Human vaccine administration will likely occur in individuals with prior or current schistosome infections.
• Investigating the impact of schistosome infection on vaccine-induced immunity is crucial for human trials.

Purpose of the Study:

• To determine if schistosome infection compromises vaccine-induced immunity in olive baboons.
• To evaluate the accuracy of indirect measures of infection intensity for assessing vaccine efficacy in human trials.

Main Methods:

• Olive baboons were vaccinated and exposed to schistosome infection, with some receiving chemotherapy.
• Immune responses (IgM, IgG) were monitored following vaccination and infection.
• Worm burden was assessed as a definitive measure of protection.
• Fecal eggs and circulating antigens were used as indirect measures of infection intensity.

Main Results:

• Neither prior nor ongoing schistosome infection diminished vaccine-induced protection.
• IgM responses were transient, while IgG responses increased with repeated vaccination.
• Indirect measures (fecal eggs, circulating antigens) consistently overestimated protection compared to worm burden.
• Assay sensitivity threshold was identified as the primary reason for overestimation.

Conclusions:

• Schistosomiasis vaccine-induced immunity is not compromised by infection in baboons.
• Current indirect measures of infection intensity require improvement for accurate assessment of vaccine efficacy in human schistosomiasis trials.
• More sensitive diagnostic tools are needed to reliably evaluate schistosome vaccine effectiveness in human populations.